Switzerland hits antibiotic use record but deaths from resistant bacteria double
Switzerland achieves major reduction in antibiotic use but bacterial resistance remains a growing concern. Despite surpassing national targets ahead of schedule, deaths from multi-resistant bacteria have doubled since 2010.
Switzerland hits antibiotic use record but bacterial resistance rises
Switzerland has achieved a significant reduction in antibiotic use, surpassing national targets ahead of schedule, but a major problem persists: deaths from resistant bacteria have doubled since 2010.
According to the latest report from Swiss federal authorities, human healthcare antibiotic consumption has reached its lowest recorded level, dropping to 9.9 daily doses per 1,000 inhabitants in 2025. This result is 11% lower than in 2024 and 4% lower than in 2019, before the COVID-19 pandemic.
Switzerland has met the national target for 2027, aiming for a reduction to 10.2 daily doses. Compared to the European average of 20.4 daily doses per 1,000 inhabitants in 2024, Switzerland stands out as one of the most successful countries in cutting antibiotic use.
Deaths from resistant bacteria double
Despite the drop in antibiotic use, bacterial resistance remains a critical issue. According to the “Swiss Antibiotic Resistance Report 2026,” the number of deaths linked to multi-resistant bacteria rose from 135 cases in 2010 to 258 cases in 2024. This highlights that antibiotic resistance remains a major threat, even in countries where antibiotic consumption is relatively low.
Regional disparities and misuse
The report also reveals significant regional differences in antibiotic use between French-speaking and German-speaking areas. In western Switzerland, where French is more prevalent, antibiotics are prescribed over 1.5 times more frequently than in the German-speaking regions. The canton of Geneva has a high consumption rate of 11.8 daily doses per 1,000 inhabitants, while Appenzell Innerrhoden records just 4.5 doses.
Furthermore, 85.9% of antibiotics are prescribed outside hospitals, primarily by general practitioners. Nearly half of the prescriptions issued by family doctors relate to respiratory tract infections, many of which are caused by viruses—against which antibiotics are ineffective. Tragically, about one in five antibiotic prescriptions in outpatient care do not align with medical guidelines.
Antibiotic use in animals
Swiss authorities have also noted a decline in antibiotic use in the veterinary sector, though the presence of the resistant MRSA bacterium, specifically type CC398, among breeding pigs remains a concern. The percentage of animals testing positive for this bacterium has risen from 2% in 2009 to 69% in 2024.
National strategy against resistance
The report is part of Switzerland’s National Strategy Against Antibiotic Resistance (StAR), which aims to promote responsible antibiotic use and limit the spread of resistant bacteria. Health authorities emphasize that while Switzerland has achieved positive results in reducing consumption, improving the quality of antibiotic prescriptions and continuing to monitor bacterial resistance remains essential for public health.
In brief
Switzerland has made significant progress in reducing antibiotic use, surpassing national targets ahead of schedule. However, bacterial resistance remains a critical issue, with deaths from resistant bacteria doubling since 2010. Swiss authorities stress the need to enhance the quality of antibiotic prescriptions and maintain monitoring of bacterial resistance to safeguard public health.
Mentioned individuals and entities
Source: albinfo.ch
Note: This material has been processed for informational purposes by Kosova.Today Portal.